Related Experiment Videos
Cortisol, 11beta-hydroxysteroid dehydrogenases, and hypertension
Stan H M van Uum1, Jacques W M Lenders, Ad R M M Hermus
1Division of Endocrinology and Metabolism, Department of Medicine, University of Western Ontario, London, Ontario, Canada.
This study explores how cortisol metabolism influences blood pressure. It focuses on the 11beta-hydroxysteroid dehydrogenase enzymes, which convert cortisol to cortisone and vice versa. Reduced activity of one enzyme, 11beta-HSD2, in the kidney allows cortisol to bind to mineralocorticoid receptors, leading to high blood pressure and low potassium levels. This can occur in genetic conditions or from licorice consumption. High cortisol levels from ectopic ACTH production also overwhelm enzyme capacity, causing hypertension. The study also considers how enzyme activity in other tissues may affect blood pressure. However, the role of extrarenal enzyme activity is not yet clear. More research is needed to fully understand how these enzymes influence hypertension.
Area of Science:
- Endocrinology and metabolic disorders
- Hypertension and cardiovascular research
- Steroid hormone metabolism
Background:
Elevated cortisol levels are linked to increased blood pressure. However, the mechanisms by which cortisol influences hypertension remain unclear. Prior research has shown that cortisol affects mineralocorticoid receptor activity in the kidneys. But the role of cortisol metabolism in blood pressure regulation is not fully understood. This uncertainty has driven investigations into how cortisol is processed in the body. Specifically, the 11beta-hydroxysteroid dehydrogenase enzymes are key in this process. These enzymes convert cortisol to cortisone and vice versa. Their activity determines how much cortisol can bind to mineralocorticoid receptors. In some cases, reduced enzyme activity leads to high blood pressure and low potassium levels.
Purpose Of The Study:
This study aimed to explore the relationship between cortisol metabolism and hypertension. It focused on the role of 11beta-hydroxysteroid dehydrogenase isozymes in regulating cortisol effects. Researchers wanted to clarify how enzyme activity influences blood pressure. They examined both renal and extrarenal enzyme activity in normotensive and hypertensive individuals. The study also considered how dietary salt affects enzyme function. They wanted to understand the consequences of enzyme deficiency on mineralocorticoid receptor access. Additionally, they looked at how high cortisol levels impact blood pressure. The goal was to assess the broader implications of altered enzyme activity in hypertension.
Main Methods:
The study reviewed existing literature on cortisol metabolism and hypertension. It analyzed the function of 11beta-hydroxysteroid dehydrogenase isozymes in various tissues. Researchers compared enzyme activity in normotensive and hypertensive individuals. They examined the effects of enzyme deficiency in genetic and acquired conditions. The study included data from patients with Apparent Mineralocorticoid Excess syndrome. They also considered the impact of licorice consumption on enzyme activity. Researchers evaluated how high cortisol levels affect mineralocorticoid receptor saturation. They looked at extrarenal enzyme activity and its potential role in blood pressure regulation.
Main Results:
Reduced renal 11beta-HSD2 activity is linked to mineralocorticoid hypertension. This occurs when cortisol binds to mineralocorticoid receptors in the kidney. Patients with Apparent Mineralocorticoid Excess syndrome show this pattern. Licorice consumption can also reduce enzyme activity and raise blood pressure. High-salt diets in normotensive individuals correlate with mild enzyme activity decreases. This suggests a possible role in blood pressure elevation. Ectopic ACTH production leads to high cortisol levels that overwhelm enzyme capacity. This results in mineralocorticoid hypertension. Extrarenal enzyme activity may also influence blood pressure, though evidence is limited.
Conclusions:
The study suggests that 11beta-HSD2 activity is crucial in preventing cortisol from binding to mineralocorticoid receptors. Reduced enzyme activity in the kidney can lead to hypertension and hypokalemia. Both genetic and acquired conditions can affect enzyme function. High cortisol levels from ectopic ACTH production may cause mineralocorticoid hypertension. Dietary salt intake appears to influence enzyme activity in normotensive individuals. Extrarenal enzyme activity may contribute to blood pressure regulation. However, the exact role of extrarenal 11beta-HSDs remains unclear. More research is needed to fully understand the mechanisms involved.
Frequently Asked Questions
11beta-HSD2 converts active cortisol to inactive cortisone, preventing cortisol from binding to mineralocorticoid receptors in the kidney.
Licorice reduces 11beta-HSD2 activity, allowing cortisol to access mineralocorticoid receptors and increasing blood pressure.
A high-salt diet in normotensive individuals correlates with mild decreases in renal 11beta-HSD2 activity, which may raise blood pressure.
Extrarenal 11beta-HSD activity may influence blood pressure, but its exact role in hypertension remains unclear.
This condition causes reduced 11beta-HSD2 activity, leading to cortisol binding to mineralocorticoid receptors and causing hypertension.
Ectopic ACTH causes high cortisol levels that overwhelm 11beta-HSD2 capacity, resulting in mineralocorticoid hypertension.